Real-time enrollment status for this hiv-1-infection clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:08 PM UTC
| NCT Number | NCT07645287 |
| Recruiting Status | Recruiting |
| Condition | HIV-1-infection |
| Phase | PHASE2 |
| Target Enrollment | 175 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | August 6, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07645287 is currently recruiting participants. This phase2 study for hiv-1-infection is actively seeking new participants at 30 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07645287 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07645287 was last updated 3 weeks ago (August 6, 2026). HelloStudys verifies this status automatically.